CAS RN: 137173-46-7
DDHL
Product Availability
Choose a grade to view its available package options.
5 package records4 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250901 |
10mg / 50mg / 250mg / 1g / 5g |
Confirm by inquiry |
Shanghai, Shandong, Chongqing, Hebei | Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20260225 |
100mg |
In stock |
Shanghai | Inquiry |
| Batchno.20260318 |
1g |
Out of stock |
| Inquiry |
| Batchno.20260213 |
250mg |
In stock |
Shanghai | Inquiry |
| Batchno.20251205 |
50mg |
In stock |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g
- Available purity: >95%
- Inventory rows with stock: 2
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 137173-46-7
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>95% |
2
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
>95% |
2
In Stock
|
Beijing |
Inquiry |
137173-46-7 / N-[(3S)-2-oxooxolan-3-yl]dodecanamide
Standard CAS: 137173-46-7
Multi CAS: No
Basic Information
CAS
137173-46-7
Multi CAS
No
Molecular Formula
C16H29NO3
Molecular Weight
283.410000
Exact Mass
283.214744
SMILES
CCCCCCCCCCCC(=O)N[C@H]1CCOC1=O
InChI
InChI=1S/C16H29NO3/c1-2-3-4-5-6-7-8-9-10-11-15(18)17-14-12-13-20-16(14)19/h14H,2-13H2,1H3,(H,17,18)/t14-/m0/s1
InChIKey
WILLZMOKUUPJSL-AWEZNQCLSA-N
Computed Properties
Structural Parameters
Heavy atom count
20
Fraction Csp3
0.88
Rotatable bonds
11
H-bond acceptors
3
H-bond donors
1
Molar refractivity
79.35
TPSA
55.4
LogP / Solubility
WLOGP
3.34
MLOGP
2.95
XLogP3
4.8
Consensus LogP
3.7
Log S (ESOL)
-2.97
Class (ESOL)
Moderately soluble
Log S (Ali)
-4.29
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.59
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.08
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
No
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
2
Safety & Transport
GHS Hazard Statements
H413 (100%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]
Precautionary Statement Codes
P273, and P501